Company Filing History:

9 out of 712

The Rockefeller University

patents

1 out of 27

The Rockfeller University

patents

Years Active: 2002-2015

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9109033 - Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof (2015-08-18),

2. 8637020 - Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof (2014-01-28),

3. 8399628 - Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof (2013-03-19),

4. 7622442 - Protein belonging to the TNF superfamily involved in signal transduction and methods of use thereof (2009-11-24),

5. 7393927 - Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof (2008-07-01),

6. 7063960 - Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof (2006-06-20),

7. 7019119 - Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof (2006-03-28),

8. 6900050 - DNA encoding TRIP (2005-05-31),

9. 6492124 - Trance activated signal transduction pathways in osteoclasts (2002-12-10),

10. 6346605 - Signal transducer for the TNF receptor super family, and uses thereof (2002-02-12),

Title: Yongwon Choi: Innovator in Immune Modulation

Introduction

Yongwon Choi is a prominent inventor based in New York, NY, known for his significant contributions to the field of immunology. With a total of 10 patents to his name, he has made remarkable strides in understanding and modulating immune responses.

Latest Patents

One of his latest patents involves a protein belonging to the TNF superfamily that plays a crucial role in signal transduction. This patent discloses a method for modulating immune response in an animal by interacting immature dendritic cells with an antigen ex vivo. The process induces maturation of these cells, which are then contacted with a modulator comprising TRANCE or its variants. After this interaction, the mature dendritic cells are introduced back into the animal, resulting in a modulated immune response towards the antigen. This innovative method aims to enhance the immune response in the animal compared to those that did not undergo this process.

Career Highlights

Yongwon Choi has worked at prestigious institutions, including The Rockefeller University, where he has contributed to groundbreaking research in immunology. His work has been instrumental in advancing our understanding of immune modulation and its applications.

Collaborations

Throughout his career, Choi has collaborated with notable colleagues such as Brian Wong and Regis Josien, further enriching his research endeavors.

Conclusion

Yongwon Choi's innovative work in immune modulation highlights his significant impact on the field of immunology. His patents and research continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com